Karin Hansson

Chief Executive Officer at

Scandibio Therapeutics AB

63 year

51 connections

Health Technology

Consumer Services

Commercial Services

Profile

Karin Marianne Hansson is the founder of Scandibio Therapeutics AB, founded in 2017, serving as Chief Executive Officer.
Dr. Hansson is the founder of Amylonix AB, founded in 2018, serving as Chief Executive Officer & Director.
Dr. Hansson is the founder of Scandiedge Therapeutics AB, founded in 2017, serving as Chief Executive Officer & Director.
Dr. Hansson is also the founder of Affibody AB,Protemedge AB,A05 Diagnostics AB..
Dr. Hansson is Chief Executive Officer & Director at Mariham Consulting AB. Dr. Hansson is Chief Executive Officer at Zytox Therapeutics AB. Former positions include Chief Executive Officer at Atlas Antibodies AB from 2006 to 2017, Independent Director at Q-linea AB from 2018 to 2023, Independent Director at Intervacc AB, Director at Atlas Therapeutics AB, Deputy Director at Antibodies Incentive AB, and Manager-Business Development at Affibody Medical AB. Education includes a graduate degree conferred in 1989 and a doctorate conferred in 1998, both from the Royal Institute of Technology.

Karin Hansson active positions

Companies	Position	Start
Scandibio Therapeutics AB Scandibio Therapeutics AB Miscellaneous Commercial ServicesCommercial Services Provides science and technology research and development services	Chief Executive Officer	01/11/2017
Amylonix AB Amylonix AB Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals focused on neurodegenerative area	Founder	01/02/2018
Scandiedge Therapeutics AB	Founder	01/11/2017
Mariham Consulting AB	Chief Executive Officer	-
Protemedge AB	Founder	-
A05 Diagnostics AB	Chief Executive Officer	-

All active positions of Karin Hansson

Former positions of Karin Hansson

Companies	Position	End
Q-LINEA AB	Director/Board Member	13/06/2023
Atlas Antibodies AB Atlas Antibodies AB BiotechnologyHealth Technology Develops, produces and markets reagents for biomedical research	Chief Executive Officer	01/08/2017
Antibodies Incentive AB	Corporate Officer/Principal	-
░░░░░ ░░░░░░░░░░░░ ░░	░░░░░░░░░░░░░░ ░░░░░░	-
░░░░░░░░ ░░░░░░░ ░░	░░░░░░░░░ ░░░░░░░░░░░░░░░░░	-

See the detail of Karin Hansson's experience

Training of Karin Hansson

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Karin Hansson's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	14
Affibody AB Affibody AB BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops radioligand therapies for cancer treatment	Health Technology
Affibody Medical AB Affibody Medical AB Pharmaceuticals: MajorHealth Technology Provides biopharmaceuticals services	Health Technology
Royal Institute of Technology Royal Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Atlas Antibodies AB Atlas Antibodies AB BiotechnologyHealth Technology Develops, produces and markets reagents for biomedical research	Health Technology
Q-linea AB Q-linea AB Medical SpecialtiesHealth Technology Develops procedures, instruments, and systems for protein and nucleic acid analysis	Health Technology
Intervacc AB Intervacc AB BiotechnologyHealth Technology Develops and produces vaccines for the animal health sector	Health Technology
Atlas Therapeutics AB Atlas Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops and manufactures antibodies drugs	Health Technology
Antibodies Incentive AB
Scandibio Therapeutics AB Scandibio Therapeutics AB Miscellaneous Commercial ServicesCommercial Services Provides science and technology research and development services	Commercial Services
Amylonix AB Amylonix AB Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals focused on neurodegenerative area	Health Technology
Scandiedge Therapeutics AB
Mariham Consulting AB
Protemedge AB
A05 Diagnostics AB